Vicarious Surgical (RBOT) Restructuring Costs (2021 - 2022)
Vicarious Surgical (RBOT) posted quarterly Restructuring Costs of $1.5 million for Q1 2022, up 1061.54% year-over-year from $130000.0 in Q1 2021, and up 1061.54% quarter-over-quarter from $130000.0 in Q1 2021.
Vicarious Surgical (RBOT) Restructuring Costs (2021 - 2022) Analysis & Trends
Vicarious Surgical (RBOT) has reported Restructuring Costs for 2 consecutive years, with $1.5 million the latest figure, recorded in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1.51 Mn |
| Mar 31, 2021 | 130,000.00 |